Cefiderocol as Salvage Therapy for Carbapenem-Resistant Klebsiella pneumoniae Sepsis in an Extremely Preterm Neonate

Indian J Pediatr. 2023 Mar;90(3):310. doi: 10.1007/s12098-022-04468-7. Epub 2023 Jan 13.

Authors

Sameer Bawankule¹, Neha Nabar¹, Preetha Joshi¹, Tanu Singhal²

Affiliations

¹ Department of Pediatrics, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Four Bungalows, Andheri West, Mumbai, Maharashtra, 400053, India.
² Department of Pediatrics, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Four Bungalows, Andheri West, Mumbai, Maharashtra, 400053, India. tanusinghal@yahoo.com.

PMID: 36637637
DOI: 10.1007/s12098-022-04468-7

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
Carbapenem-Resistant Enterobacteriaceae*
Carbapenems
Cefiderocol
Humans
Infant, Extremely Premature
Infant, Newborn
Klebsiella pneumoniae
Microbial Sensitivity Tests
Salvage Therapy
Sepsis* / drug therapy

Substances

Anti-Bacterial Agents
Carbapenems